Burke et al reported a staging system for a patient with hilar cholangiocarcinoma. The authors are from Memorial Sloan-Kettering Cancer Center.
Patient selection: hilar cholangiocarcinoma
Parameters:
(1) extent of tumor
(2) portal vein involvement
(3) liver atrophy
Extent of Tumor
Portal Vein Involvement
Liver Atrophy
Stage
confluence and/or right or left hepatic duct
absent
absent
T1
confluence and/or left or right hepatic duct
absent
ipsilateral liver atrophy
T2
confluence and/or left or right hepatic duct
ipsilateral portal venous branch without involving main portal vein
NA
T3
both left and right hepatic ducts up to secondary radicles bilaterally
NA
NA
T4
NA
encasement of main portal vein
NA
T4
The survival of hilar cholangiocarcinoma is impact by the status of the resection margin. A patient with a positive margin has a worse overall survival.
To read more or access our algorithms and calculators, please log in or register.
